Skip to content

Voxcell BioInnovation

2 viewers · 30d

Total raised

—

No Form D filings on record

No Form D filings on record
LAST ROUND
N/A
ROUNDS
0
INVESTORS
10
FOUNDED
2020
HQ
N/A
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

VoxCell BioInnovation Inc. is a pioneering biotechnology company specializing in innovative solutions to enhance the drug development process, particularly within the oncology sector. By focusing on reducing the high failure rate in drug development, VoxCell aims to streamline preclinical testing and ultimately decrease both time and costs involved.

What sets it apart

VoxCell stands out with its state-of-the-art 3D bioprinting technologies and unique vascularized cancer tissue models, which provide a more accurate representation of human tumors.

Products

1 tracked

Vascularized Cancer Tissue Models

Bioprinted Models

VoxCell's vascularized cancer tissue models are advanced 3D bioprinted constructs that closely mimic the tumor microenvironment. These models serve as effective screening platforms for drug candidates in preclinical testing, providing researchers and pharmaceutical companies with valuable data regarding the efficacy of potential therapies.

  • 3D bioprinted human-like structures
  • Replicates tumor microenvironment
  • Enhances accuracy in drug testing

Links

WebsiteSEC EDGAR filings